Relmada Therapeutics to Report Fourth Quarter 2025 Financial Results on Thursday, March 19, 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/26/2026

1. ON
2. SYNA
3. MU
4. MKC
5. DRI
6. FDXF
7. VEON
8. SHPH
9. NKE
10. HIVE

Go back to Relmada Therapeutics to Report Fourth Quarter 2025 Financial Results on Thursday, March 19, 2026
(NASDAQ: RLMD) Delayed: 6.45 --0 (-0%)
Previous Close $6.45    52 Week High $4.10 
Open $6.45    52 Week Low $0.87 
Day High $6.45    P/E N/A 
Day Low $6.45    EPS $0.00 
Volume 78